Health Innovation

MIAMI, Sept. 16, 2026 /PRNewswire/ -- Armor Health (ArmorHealthcare.com), a national provider

DEEp SEA is a global Phase III trial evaluating efficacy, safety and

First FDA-approved stent designed specifically for the smallest patients with certain congenital

Anti-B7-H3 antibody-drug conjugate reduced the risk of death by 54% versus topotecan

Ribbon-cutting held on World Suicide Prevention DayRED BANK, N.J., Sept. 12, 2026

Hospitals support 5,500 jobs while serving communities facing significant health, economic and

Locally owned wellness destination will offer private infrared sauna and red light

Researchers provided biological expertise and feedback that helped guide the development of

Following 100% transfusion independence in Chinese TDT patients, new study confirms tBE